Guided by immigrant roots, public‑health purpose and a belief in “staying in the ring,” Novartis CEO Vas Narasimhan reflects on the unlikely decisions that took him from the “steel town” of Pittsburgh, Pennsylvania to the helm of a global drugmaker.
In this video
Get this delivered to your inbox, and more info about our products and services.
Vas Narasimhan, CEO of pharmaceuticals company, Novartis, discusses the company's latest $12 billion acquisition of Avidity…
Novartis CEO Vas Narasimhan told CNBC in Davos that he believes the Swiss drugmaker is protected from any additional U.S. tariffs…
Roy Jakobs reflects on the early experiences that shaped his leadership—from post‑war lessons in forgiveness to the resilience…
Novartis "can never be done" when it comes to major acquisitions in its sector, CEO Vas Narasimhan told CNBC.
Also: All the news and watercooler chat from Fortune.
Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…
